Baxter International Inc. – NYSE:BAX
Baxter International stock price today
$24.29
-4.91
-16.82%
Financial Health
0
1
2
3
4
5
6
7
8
9
Market open
Closed in about 3 hours
Baxter International stock price monthly change
-17.33%
month
Baxter International stock price quarterly change
-17.33%
quarter
Baxter International stock price yearly change
-24.47%
year
Baxter International key metrics
Market Cap | 14.86B |
Enterprise value | 26.68B |
P/E | 137.88 |
EV/Sales | 1.90 |
EV/EBITDA | 13.89 |
Price/Sales | 1.06 |
Price/Book | 1.89 |
PEG ratio | 50.21 |
EPS | -0.45 |
Revenue | 14.89B |
EBITDA | 1.65B |
Income | 2.64B |
Revenue Q/Q | -1.56% |
Revenue Y/Y | -1.08% |
Profit margin | 0.77% |
Oper. margin | 4.46% |
Gross margin | 37.78% |
EBIT margin | 4.46% |
EBITDA margin | 11.11% |
Sign up &
create your own Smart Feed
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeBaxter International stock price history
Baxter International stock forecast
Baxter International financial statements
| Jun 2023 | 3.70B | -141M | -3.8% |
|---|---|---|---|
| Sep 2023 | 3.70B | 2.50B | 67.64% |
| Dec 2023 | 3.88B | 245M | 6.31% |
| Mar 2024 | 3.59B | 37M | 1.03% |
| Mar 2024 | 3.59B | 37M | 1.03% |
|---|---|---|---|
| Sep 2025 | 3.91B | 423.11M | 10.81% |
| Oct 2025 | 3.91B | 416.51M | 10.64% |
| Dec 2025 | 4.11B | 452.82M | 11.01% |
Analysts Price target
Financials & Ratios estimates
Paying a dividend greater than earnings.
3.56%
Yield TTM
| Payout ratio | 546.3% |
|---|
| 2019 | 0.99% |
|---|---|
| 2020 | 1.16% |
| 2021 | 1.23% |
| 2022 | 2.23% |
| 2023 | 3% |
| Jun 2023 | 27885000000 | 22.25B | 79.81% |
|---|---|---|---|
| Sep 2023 | 30656000000 | 22.49B | 73.36% |
| Dec 2023 | 28276000000 | 19.80B | 70.05% |
| Mar 2024 | 27788000000 | 19.55B | 70.36% |
| Jun 2023 | 351M | -173M | -120M |
|---|---|---|---|
| Sep 2023 | 365M | 3.78B | -62M |
| Dec 2023 | 531M | -230M | -2.93B |
| Mar 2024 | 163M | -166M | -140M |
Baxter International alternative data
| Aug 2023 | 60,000 |
|---|---|
| Sep 2023 | 60,000 |
| Oct 2023 | 60,000 |
| Nov 2023 | 60,000 |
| Dec 2023 | 60,000 |
| Jan 2024 | 60,000 |
| Feb 2024 | 60,000 |
| Mar 2024 | 60,000 |
| Apr 2024 | 60,000 |
| May 2024 | 60,000 |
| Jun 2024 | 60,000 |
| Jul 2024 | 60,000 |
Baxter International other data
83.42%
-1.10%
of BAX is owned by hedge funds
1.10K
-18
423.78M
-3.91M
shares is hold by hedge funds
What is insider trading?
| Period | Buy | Sel |
|---|---|---|
| Mar 2024 | 0 | 64488 |
| Patent |
|---|
Application Filling date: 26 May 2022 Issue date: 8 Sep 2022 |
Grant Filling date: 8 May 2020 Issue date: 6 Sep 2022 |
Application A DIALYSIS MACHINE, A FLUID PREPARATION DEVICE, AND METHODS FOR ESTABLISHING SECURE COMMUNICATION BETWEEN A DIALYSIS MACHINE AND A FLUID PREPARATION DEVICE Filling date: 23 May 2022 Issue date: 1 Sep 2022 |
Application COLLAGEN MATRIX AND N-HYDROXYLSUCCINIMIDE FUNCTIONALIZED POLYETHYLENE GLYCOL STAPLE LINE REINFORCEMENT Filling date: 22 Feb 2022 Issue date: 25 Aug 2022 |
Grant Filling date: 4 Nov 2019 Issue date: 23 Aug 2022 |
Grant Filling date: 29 Oct 2018 Issue date: 16 Aug 2022 |
Application Filling date: 8 Feb 2022 Issue date: 11 Aug 2022 |
Grant Utility: Device, system and method for mixing Filling date: 13 Mar 2017 Issue date: 9 Aug 2022 |
Application Filling date: 22 Apr 2022 Issue date: 4 Aug 2022 |
Grant Filling date: 30 Mar 2018 Issue date: 2 Aug 2022 |
| Quarter | Transcript |
|---|---|
| Q1 2024 2 May 2024 | Q1 2024 Earnings Call Transcript |
| Q4 2023 8 Feb 2024 | Q4 2023 Earnings Call Transcript |
| Q3 2023 2 Nov 2023 | Q3 2023 Earnings Call Transcript |
| Q2 2023 27 Jul 2023 | Q2 2023 Earnings Call Transcript |
Baxter International: A Possible Value Trap
Baxter International: Shares Too Cheap, EPS Growth Ahead With A Possible Spinoff
MoneyShow's Best Investment Ideas For 2024: Part 2
Baxter International: A Cheap Big Pharma Stock With Improving Earnings And +3% Dividend Yield
Should You Buy Baxter Or DaVita After The Fallout From The Ozempic Trial?
iRhythm Technologies: Unpacking The FDA Warning Letter
Lifecore: Extraordinary Upside Likely Despite Bankruptcy Concerns
3 Reasons To Consider A Nibble On Baxter
ResMed: Bulls Can Rest For Now, For Its Declining Cash Flow Performance
-
What's the price of Baxter International stock today?
One share of Baxter International stock can currently be purchased for approximately $24.29.
-
When is Baxter International's next earnings date?
Unfortunately, Baxter International's (BAX) next earnings date is currently unknown.
-
Does Baxter International pay dividends?
Yes, Baxter International pays dividends and its trailing 12-month yield is 3.56% with 546% payout ratio.It means that the company is paying a dividend greater than earnings. The last Baxter International stock dividend of $0.28 was paid on 3 Jan 2022.
-
How much money does Baxter International make?
Baxter International has a market capitalization of 14.86B and it's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 1.99% to 14.81B US dollars.
-
What is Baxter International's stock symbol?
Baxter International Inc. is traded on the NYSE under the ticker symbol "BAX".
-
What is Baxter International's primary industry?
Company operates in the Healthcare sector and Medical - Instruments & Supplies industry.
-
How do i buy shares of Baxter International?
Shares of Baxter International can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Baxter International's key executives?
Baxter International's management team includes the following people:
- Mr. Jose E. Almeida Chairman, Pres & Chief Executive Officer(age: 63, pay: $1,370,000)
- Mr. Cristiano Franzi Senior Vice President & Pres for EMEA(age: 62, pay: $1,330,000)
- Mr. Giuseppe Accogli Executive Vice President & Chief Operating Officer(age: 54, pay: $1,090,000)
- Mr. James K. Saccaro Executive Vice President & Chief Financial Officer(age: 52, pay: $1,080,000)
- Mr. Sean B. W. Martin Senior Vice President & Gen. Counsel(age: 62, pay: $943,450)
-
How many employees does Baxter International have?
As Jul 2024, Baxter International employs 60,000 workers.
-
When Baxter International went public?
Baxter International Inc. is publicly traded company for more then 43 years since IPO on 27 Oct 1981.
-
What is Baxter International's official website?
The official website for Baxter International is baxter.com.
-
Where are Baxter International's headquarters?
Baxter International is headquartered at One Baxter Parkway, Deerfield, IL.
-
How can i contact Baxter International?
Baxter International's mailing address is One Baxter Parkway, Deerfield, IL and company can be reached via phone at +224 9482000.
Baxter International company profile:
Baxter International Inc.
baxter.comExchange:
NYSE
Full time employees:
60,000
Industry:
Medical - Instruments & Supplies
Sector:
Healthcare
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug platforms, inhaled anesthesia and critical care products and pharmacy compounding services; parenteral nutrition therapies and related products; biological products and medical devices used in surgical procedures for hemostasis, tissue sealing and adhesion prevention; and continuous renal replacement therapies and other organ support therapies focused in the intensive care unit. It also provides connected care solutions, including devices, software, communications, and integration technologies; integrated patient monitoring and diagnostic technologies to help diagnose, treat, and manage a various illness and diseases, including respiratory therapy, cardiology, vision screening, and physical assessment; surgical video technologies, tables, lights, pendants, precision positioning devices and other accessories. In addition, the company offers contracted services to various pharmaceutical and biopharmaceutical companies. Its products are used in hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors' offices, and patients at home under physician supervision. The company sells its products through direct sales force, as well as through independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers in approximately 100 countries. It has an agreement with Celerity Pharmaceutical, LLC to develop acute care generic injectable premix and oncolytic molecules. Baxter International Inc. was incorporated in 1931 and is headquartered in Deerfield, Illinois.
One Baxter Parkway
Deerfield, IL 60015
Deerfield, IL 60015
CIK: 0000010456
ISIN: US0718131099
CUSIP: 071813109
